Replies to post #185684 on Biotech Values

[DewDiligence]

ADXS wants an SPA for lead program (brief video):

http://www.thestreet.com/video/13013048/advaxis-ceo-institutional-interest-in-immunotherapy-driving-stock.html

The CEO says they have enough cash to last until mid 2016, although I take that with a grain of salt.

This one of my 2015 SI charity picks.